Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Entacapone (Comtan) and Tolcapone (Tasmar) are both COMT inhibitors used to treat Parkinson's disease (PD) by enhancing the effects of carbidopa/levodopa. However, there are some key differences between the two. Entacapone (Comtan) must be taken with every dose of carbidopa/levodopa, while Tolcapone (Tasmar) is taken three times a day. Entacapone (Comtan) and Tolcapone (Tasmar) are both available in both brand-name and generic forms. Tolcapone (Tasmar) has a risk of causing serious liver damage, requiring regular liver monitoring, and is not suitable for people with liver problems. Both medications can cause side effects like involuntary movements and nausea. Additionally, both Entacapone (Comtan) and Tolcapone (Tasmar) can make you very sleepy, but Tolcapone can also cause excessive dreaming.
Entacapone (Comtan)
Tolcapone (Tasmar)
Entacapone (Comtan)
Tolcapone (Tasmar)
Summary of Entacapone vs. Tasmar
Summary for COMT inhibitor
Prescription only
Entacapone (Comtan) is used for Parkinson's disease (PD) and helps relieve symptoms like shakiness and slowed movement. It's used along with the combination medication carbidopa/levodopa. Entacapone (Comtan) is a good option for people whose levodopa wears off before their next dose ("wearing-off" periods). But, this medication has to be taken every time you take carbidopa/levodopa for it to work properly. Some side effects include involuntary movements (dyskinesia) and nausea. Entacapone (Comtan) is available as a brand-name and generic medication.
Summary for COMT inhibitor
Prescription only
Tolcapone (Tasmar) is an oral add-on medication for Parkinson's disease (PD). It's usually used when carbidopa/levodopa isn't controlling PD symptoms well enough.
Indications of Entacapone vs. Tasmar
Indications for
•Relief of "wearing-off" symptoms in people with Parkinson's disease who are taking carbidopa/levodopa medications (e.g., Sinemet, Rytary)
Indications for
•Parkinson's disease (PD); as add-on treatment to carbidopa/levodopa